Bay Harbor Wealth Management’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Bay Harbor Wealth Management’s Portfolio KLDO Stock Details KLDO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$0	Hold	2,300	–	–	﹤0.01%	1352
2025 Q4	$0	Buy	+2,300	New	–	﹤0.01%	1352
2025 Q3	–	Sell	-2,300	Closed	–	–	1325
2025 Q2	$0	Hold	2,300	–	–	﹤0.01%	1314
2025 Q1	$2	Buy	+2,300	New	+$2	﹤0.01%	1148
2024 Q4	–	Sell	-2,300	Closed	–	–	193
2024 Q3	$0	Buy	+2,300	New	–	﹤0.01%	180
2024 Q2	–	Sell	-2,300	Closed	–	–	182
2024 Q1	$0	Buy	+2,300	New	–	﹤0.01%	184

Bay Harbor Wealth Management's KLDO Position: Q1 2026 in Review

Bay Harbor Wealth Management held its Kaleido Biosciences, Inc. Common Stock (KLDO) position steady in Q1 2026 at 2,300 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1352.

Bay Harbor Wealth Management first reported a position in KLDO in Q1 2024 and has held it in 6 quarters since. The position peaked at $2 in Q1 2025. 3 funds tracked by Wall St. Rank hold KLDO as of Q1 2026.

Bay Harbor Wealth Management held 2,300 shares of Kaleido Biosciences, Inc. Common Stock worth $0 as of Q1 2026.
Bay Harbor Wealth Management left its Kaleido Biosciences, Inc. Common Stock share count unchanged in Q1 2026.
Kaleido Biosciences, Inc. Common Stock made up ﹤0.01% of Bay Harbor Wealth Management's portfolio in Q1 2026, its #1352 holding.
Bay Harbor Wealth Management first reported a position in Kaleido Biosciences, Inc. Common Stock in Q1 2024 and has held it in 6 quarters since.
Bay Harbor Wealth Management's Kaleido Biosciences, Inc. Common Stock position peaked at $2 in Q1 2025.
3 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q1 2026.

Based on Bay Harbor Wealth Management's 13F filing for Q1 2026, filed 14 Apr 2026.